NeoGenomics expands Indica Labs partnership to scale AI-powered digital pathology
NEO•NeoGenomics expanded its partnership with Indica Labs to scale digital pathology infrastructure and accelerate AI-driven diagnostics across its enterprise.
1. Expanded collaboration
The collaboration will use Indica Labs' cloud-based HALO AP platform to integrate third-party or internally developed AI tools while limiting integration costs. The infrastructure is expected to support emerging AI-based biomarker testing, future AI co-development and clinical trial collaborations.
